cigna glp 1 2025 requirements Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss GLP-1 Pipeline Update: May 2025

Incredible value for FDA-approved care

The agency highlighted serious violations in the company's reporting

Saxenda specifically licensed for weight management) [2] [5] Dulaglutide (Trulicity for diabetes only) Exenatide (Byetta, Bydureon for diabetes only) Oral semaglutide (Rybelsus for diabetes only) These medications are administered via subcutaneous injection (except Rybelsus), with dosing frequencies ranging from daily to weekly depending on the specific formulation

Gros R, You X, Baggio LL, Kabir MG, Mungrue IN, Parker TG, Huang Q, Drucker DJ, Husain M: Cardiac function in mice lacking the glucagon-like peptide-1 receptor

Research has found that GLP-1 agonists like semaglutide can even reduce the incidence of major cardiac events, like strokes and heart attacks, by 20%